JD Health International Inc.
JDHIF
$6.15
-$0.34-5.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.02B | 8.54B | 8.09B | 7.84B | 7.58B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.02B | 8.54B | 8.09B | 7.84B | 7.58B |
| Cost of Revenue | 6.87B | 6.54B | 6.24B | 6.06B | 5.87B |
| Gross Profit | 2.15B | 1.99B | 1.85B | 1.78B | 1.71B |
| SG&A Expenses | 1.64B | 1.57B | 1.50B | 1.47B | 1.43B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.71B | 8.30B | 7.92B | 7.71B | 7.48B |
| Operating Income | 311.12M | 235.50M | 161.37M | 135.28M | 109.20M |
| Income Before Tax | 723.37M | 693.78M | 666.81M | 562.66M | 457.53M |
| Income Tax Expenses | 70.26M | 79.39M | 88.87M | 92.03M | 95.05M |
| Earnings from Continuing Operations | 653.11 | 614.39 | 577.94 | 470.63 | 362.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 985.20K | 826.30K | 671.20K | 502.40K | 332.90K |
| Net Income | 654.10M | 615.22M | 578.61M | 471.13M | 362.81M |
| EBIT | 311.12M | 235.50M | 161.37M | 135.28M | 109.20M |
| EBITDA | 334.50M | 257.69M | 182.48M | 156.88M | 131.28M |
| EPS Basic | 0.21 | 0.20 | 0.18 | 0.15 | 0.12 |
| Normalized Basic EPS | 0.14 | 0.14 | 0.13 | 0.11 | 0.09 |
| EPS Diluted | 0.21 | 0.19 | 0.18 | 0.15 | 0.12 |
| Normalized Diluted EPS | 0.14 | 0.14 | 0.13 | 0.11 | 0.09 |
| Average Basic Shares Outstanding | 12.61B | 12.59B | 12.57B | 12.55B | 12.53B |
| Average Diluted Shares Outstanding | 12.71B | 12.68B | 12.64B | 12.64B | 12.64B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |